Engflag

Algoxib

Quick links to important sections

Algoxib

Algoxib_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Algoxib

Quick Facts

Property Description
Active ingredient Celecoxib
Form Capsule (Oral administration)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain and inflammation
Origin Synthetic compound

What Type of Medicine is Algoxib? (Identity and Classification)

Algoxib is a synthetic, prescription-only medicinal product. Its active ingredient is Celecoxib, which is chemically identified as a sulfonamide derivative and belongs to the overall class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). The key pharmacological feature of this drug is its classification as a selective Cyclooxygenase-2 (COX-2) inhibitor, a characteristic that differentiates it from older, non-selective NSAIDs by targeting the enzyme primarily responsible for the inflammatory response.

Celecoxib’s targeted mechanism is characterized by high selectivity against COX-2 and its clinical recognition for anti-inflammatory efficacy. This precise, selective action underlies the medication’s suitability for managing chronic inflammatory states, such as joint stiffness.

Algoxib's Composition and General Purpose (Form and Benefit)

Algoxib is formulated specifically as capsules intended for oral administration, ensuring systemic distribution of the active substance throughout the body. The composition is that of a single-active-ingredient product, combining Celecoxib with standard pharmaceutical excipients necessary for reliable delivery.

Its general purpose is the symptomatic management of discomfort, specifically by providing measurable relief from pain and inflammation. By selectively interrupting the synthesis of prostaglandins—the chemical messengers that signal inflammation—the medicine provides a consistent analgesic and anti-inflammatory action. The oral capsule form facilitates its use in typical scenarios where sustained, body-wide relief is required to improve mobility and reduce swelling associated with inflammatory conditions.

Regulatory References

  1. Celecoxib - LiverTox - NIH
  2. Celecoxib referral - European Medicines Agency (EMA)

What side effects are possible with Algoxib?

Possible side effects and safety information

The official safety profile for Algoxib (Celecoxib) details a range of documented adverse reactions, which are classified by their frequency of occurrence and the physiological system they affect. These classifications are based on aggregated data from clinical trials and post-marketing surveillance, consistent with regulatory standards.

Adverse Reaction Classifications

The documented effects are categorized across multiple System-Organ Classes, including Gastrointestinal Disorders, Cardiac Disorders, Vascular Disorders, and Nervous System Disorders. Reactions are formally categorized into frequency groups such as Common (ge 1/100 to < 1/10), Uncommon, Rare, and Very Rare.

Classification (Examples) Affecting System Common Examples
Common Nervous System Headache, Dizziness
Common Gastrointestinal Abdominal pain, Dyspepsia, Flatulence
Common Vascular Hypertension

Serious Safety Considerations

Official regulatory documents emphasize the potential for Serious Cardiovascular Thrombotic Events, such as myocardial infarction and stroke, which may increase with the duration of use and increasing dose. The risk of Serious Gastrointestinal Toxicity, including bleeding, ulceration, and perforation, which can be fatal, is also documented and can occur at any time during treatment.

Severe Hypersensitivity Reactions (e.g., Stevens-Johnson Syndrome) are classified as very rare but necessitate immediate attention. A key restriction is the contraindication for patients with known hypersensitivity to sulfonamides, given the medicine's chemical structure.

Population-Specific Safety Notes

The safety profile includes specific notes for certain groups. Older adults may have an increased risk for gastrointestinal and renal complications. Use during the third trimester of pregnancy is avoided due to the documented risk to the fetus's circulatory system. The medicine is contraindicated for use in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented overdose manifestations and mandated emergency actions for Algoxib (Celecoxib), based strictly on government regulatory documents.

Overdose symptoms are typically classified as potentially reversible with supportive care, but they can progress to severe outcomes. Common signs reported in NSAID overdose include lethargy, drowsiness, nausea, vomiting, and epigastric pain. More serious effects documented in the event of an acute overdose may include gastrointestinal bleeding, hypertension, acute renal failure, respiratory depression, or coma.

Emergency Response

Immediate medical attention is required for any suspected overdose. Emergency services should be called immediately if the individual is experiencing life-threatening symptoms such as collapse, seizure, trouble breathing, or inability to be awakened (Source: NIH MedlinePlus).

Management is primarily symptomatic and supportive. Regulatory information confirms that no specific antidote for Celecoxib overdose is available. Patients seen within four hours of a large overdose may receive procedural steps like activated charcoal and an osmotic cathartic to assist with management. Removal of the drug by hemodialysis is stated to be unlikely to be useful due to the drug’s high level of plasma protein binding.

Therapeutic Uses of Algoxib

Algoxib is commonly used to help manage symptoms across several key therapeutic domains characterized by symptoms related to physical discomfort, inflammatory or irritative states, and stiffness. The medication is applied when these manifestations create noticeable physiological strain and interfere with daily functioning, and is relevant when supportive symptom management is appropriate.

The medication is commonly used across conditions presenting with systemic or localized discomfort, including osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), and Juvenile Rheumatoid Arthritis (JRA). It is also applied in acute clinical scenarios where short-term symptomatic assistance is needed, such as pain following minor surgical or dental procedures and the discomfort of Primary Dysmenorrhea (menstrual cramps). The medication helps address symptom clusters of pain and stiffness, which contributes to easing the overall symptom load.

By addressing these symptom clusters, the therapy provides support that helps ease the overall symptom burden, assisting with maintaining functional stability when symptoms create noticeable functional strain.

Quick Fact: Relief for Joint Discomfort

Symptom Domain Key Benefit Target Conditions
Chronic Stiffness & Pain Supports general well-being during symptomatic phases. Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis.
Acute Pain Spikes Provides supportive relief when symptoms interfere with routine activities. Postoperative/Dental Pain, Primary Dysmenorrhea.

Regulatory References

  1. NIH MedlinePlus overview of Celecoxib

Eligibility and Restrictions for Use

Algoxib (a COX-2 selective NSAID) is generally used to relieve symptoms of osteoarthritis, rheumatoid arthritis (including juvenile idiopathic arthritis in patients 2 years and older), ankylosing spondylitis, and for the management of acute pain and primary dysmenorrhea (menstrual pain).

Contraindications (When Algoxib Should Not Be Used)

Algoxib is contraindicated for individuals with certain medical histories and conditions, as its use can be harmful. These include:

  • Allergy: A known allergy or hypersensitivity reaction (e.g., asthma, hives, allergic-type reactions) to Algoxib, other NSAIDs, aspirin, or any drugs containing a sulfonamide chemical group (e.g., certain antibiotics).
  • Heart Surgery: Pain management immediately before or after coronary artery bypass graft (CABG) surgery.
  • Active GI Issues: Active peptic ulceration or gastrointestinal bleeding.
  • Severe Organ Impairment: Severe hepatic (liver) impairment (Child-Pugh Class C) or advanced renal (kidney) disease (creatinine clearance <30 mL/min).

Warnings and Precautions

Careful consideration and caution are necessary for patients with a history of heart attack or stroke, pre-existing cardiovascular disease, uncontrolled hypertension (high blood pressure), or heart failure due to the increased risk of serious cardiovascular thrombotic events. It is generally advised to use the lowest effective dose for the shortest duration possible.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents categorize several significant interaction patterns for Algoxib (celecoxib), primarily concerning effects on bleeding risk, blood pressure control, and drug exposure.

Classification Interacting Agents / Conditions
Increased Bleeding Risk Oral anticoagulants (e.g., Warfarin), Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine Reuptake Inhibitors (SNRIs), Oral Corticosteroids.
Reduced Efficacy ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), Beta-blockers, Furosemide and Thiazide Diuretics.
Altered Drug Exposure Fluconazole, Lithium, Digoxin, Rifampin.
Food & Product Effects High-fat meals (delay absorption/increase total exposure), Aluminum- and Magnesium-containing Antacids (decrease absorption), Alcohol (increases risk of serious GI side effects).

Co-administration with Fluconazole, a strong CYP2C9 inhibitor, results in significantly increased celecoxib plasma concentrations. Conversely, co-administration with a CYP2C9 inducer like Rifampin may compromise efficacy. Celecoxib itself inhibits the CYP2D6 enzyme, potentially increasing the systemic exposure of co-administered drugs metabolized by that pathway.

Regulatory restrictions state that use is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery, and co-administration with other non-aspirin NSAIDs should be avoided due to increased risk of gastrointestinal toxicity. Furthermore, patients with a known or suspected CYP2C9 poor metabolizer genotype are noted in official labeling to be at risk for abnormally high celecoxib plasma levels.

Mechanism of Action

Selective Intervention in Prostanoid Synthesis

Algoxib's mechanism begins with its role as a selective inhibitor of the Cyclooxygenase-2 ( COX-2) enzyme. This enzyme is the primary molecular target, acting to block the conversion of arachidonic acid into pro-inflammatory prostaglandins, particularly Prostaglandin E2 ( PGE2). This selective approach is relevant in systems where targeted pathway adjustment is required, acting to modulate COX-2-driven synthesis in tissues where COX-2 expression is high.

Causal Cascade: From Enzyme Blockade to Physiological Effect

The suppression of PGE2 production directly influences the body's physiological signaling. This modifies the early molecular steps that shape systemic outcomes, as PGE2 is a potent chemical messenger that sensitizes peripheral pain fibers and elevates the thermoregulatory set point in the hypothalamus. By limiting this mediator activity both peripherally and centrally, the mechanism facilitates modulation within targeted pathways, leading to subsequent physiological changes that reduce nociceptor sensitization and reset the hypothalamic thermoregulatory set point.

Mechanism and Homeostatic Balance

The structural specificity of Algoxib for COX-2 is central to its mechanism. It is designed to largely spare the constitutive COX-1 enzyme, which is responsible for generating prostanoids involved in gastric mucosal maintenance. However, its inhibition of COX-2 that is naturally expressed in vascular tissues also affects the balance of prostanoids involved in blood vessel regulation, engaging mechanisms that influence feedback regulation within cardiovascular pathways.

Dosage and Administration Information

How to Use Algoxib

Algoxib (Celecoxib) is designed for oral administration and is available in capsule strengths of 50 mg, 100 mg, 200 mg, and 400 mg. The overarching principle of use is to utilize the lowest effective dosage for the shortest duration necessary to achieve therapeutic goals.

Administration may occur without regard to the timing of meals. For individuals who may have difficulty swallowing, the capsules may be opened and the contents mixed with one teaspoon of cool or room-temperature applesauce for immediate ingestion.

Standard Dosing Regimens (Adult)

Indication Typical Maintenance Regimen Maximum Recommended Dose (MRD)
Osteoarthritis (OA) 100 mg twice daily (BID) or 200 mg once daily (QD) 200 mg/day
Rheumatoid Arthritis (RA) 100 mg to 200 mg BID 400 mg/day
Acute Pain / Primary Dysmenorrhea 200 mg twice daily as needed (following a higher initial dose) 600 mg (Day 1 total)

Population-Specific Use

Dosage modification is documented for certain patient populations. For patients with moderate hepatic impairment (Child-Pugh Class B), the daily dose is reduced by 50%. Additionally, dosing for pediatric patients (ages 2 years and older) with Juvenile Rheumatoid Arthritis (JRA) is determined based on the patient's weight. Individuals identified as CYP2C9 poor metabolizers are also initiated on treatment with half of the lowest recommended dose.

Recent Clinical Evidence

Research evidence / Overview of Studies for Algoxib

Algoxib (celecoxib) was studied in research exploring symptoms associated with chronic arthritis and acute pain, with evidence primarily derived from randomized controlled trials (RCTs) and active-controlled comparative studies.

Chronic Joint Conditions and Symptom Patterns

For Osteoarthritis (OA), short-term trials (up to 12 weeks) examined patient-reported changes in pain intensity, joint stiffness, and functional status compared to placebo and other non-selective NSAIDs. For Rheumatoid Arthritis (RA), studies explored measured changes in disease activity markers (ACR criteria) over 12 to 24 weeks. The evidence provides insight into short-term symptom patterns; however, the impact on long-term disease progression or structural damage is not fully established, as follow-up durations were limited.

Acute Pain and Other Conditions

The medication was studied in research exploring acute, short-term outcomes related to physical discomfort, utilizing very short-term, single-dose trials for acute episodes like postoperative pain and Primary Dysmenorrhea. Measured outcomes focused on the speed of onset and the pattern of pain intensity measurements over a few hours. Dedicated research also examined the medication for Ankylosing Spondylitis (AS), utilizing disease-specific functional tools (BASDAI/BASFI), although the volume of evidence for AS is lower in published literature.

Evidence in Special Populations and Limitations

Evidence in special populations includes studies for children (aged 2–16) with Juvenile Rheumatoid Arthritis (JRA), evaluated via non-inferiority trials. Long-term effects in children are still emerging, often from post-marketing observational settings. Uncertainty remains due to limited follow-up durations in core efficacy trials, the non-inferiority design for JRA (meaning comparative evidence is lacking regarding superiority), and evidence quality that varies across studies. The results apply only to the populations studied and the specific conditions under which the research was conducted.

Frequently Asked Questions (FAQ)

Common questions about Algoxib (FAQ)

Q: Are there any foods I should avoid while taking Algoxib?

Regulatory documents indicate that co-administration with aluminum- and magnesium-containing antacids can result in decreased Algoxib levels in the body. Taking the medication with a high-fat meal can also delay how quickly it reaches its peak level, though it may increase the total amount absorbed. Outside of these specific considerations, there are no general food restrictions mentioned in the official product information.

Q: Can I take Algoxib if I have kidney problems?

Official information provides specific guidance on use in patients with kidney problems. Algoxib is contraindicated (should not be used) in people with advanced renal disease, specifically defined as a creatinine clearance of less than 30 mL/min. Caution is advised when the medication is used in patients with any degree of impaired renal function due to the potential for kidney-related toxicity.

Q: Can people with liver issues use Algoxib?

Algoxib is contraindicated for people with severe hepatic (liver) impairment, known as Child-Pugh Class C. For patients diagnosed with moderate hepatic impairment (Child-Pugh Class B), official dosing guidance indicates that the daily dose may need to be adjusted or reduced by up to 50%.

Q: How is Algoxib usually stopped? Does it need to be tapered?

Official documents note that any decision to stop the medication is a clinical one. While the official product information includes a section on discontinuation, it does not provide specific instructions on whether a dose needs to be gradually reduced or 'tapered.' Treatment should always be for the shortest duration necessary to meet therapeutic goals.

Q: How does Algoxib interact with common acid reflux medications?

Regulatory documents specifically show that Algoxib interacts with aluminum- and magnesium-containing antacids. When taken together, these antacids can lead to decreased concentrations of Algoxib in the bloodstream. Official information does not provide details on other types of acid reflux medications like H2 blockers or proton pump inhibitors (PPIs).

Q: What age group is Algoxib typically prescribed to?

Official information indicates that Algoxib is used for adults with conditions like Osteoarthritis and Rheumatoid Arthritis. It also has an established use for pediatric patients (children ages ge 2 years) who have been diagnosed with Juvenile Rheumatoid Arthritis.

Q: Are there specific symptoms that mean I should stop taking Algoxib?

Regulatory safety information advises that if you experience certain symptoms of serious events, such as chest pain, shortness of breath, slurred speech, swelling of the face, or the first sign of a skin rash, emergency medical attention should be sought. Regulatory documents state that discontinuation of the medication may be necessary.

Q: Do I need to stop taking Algoxib before surgery?

Official regulatory information advises that individuals should inform their doctor or dentist that they are taking Algoxib if they are scheduled to have any type of surgery, including dental surgery. This practice is consistent with regulatory recommendations for safe use during medical procedures.

Q: What happens if I miss a dose of Algoxib?

If a dose is missed, the label advises the missed dose should generally be skipped to prevent taking a double dose, and the patient should resume the regular dosing schedule. This guidance is in line with official drug information.

Q: Is Algoxib safe for elderly patients?

Regulatory documents include specific considerations for older adult patients. They may have an increased risk for side effects, particularly those affecting the stomach, intestines, and kidneys. Regulatory guidance often indicates that the lowest effective dose for the shortest duration should be considered in this population.

Q: Can young adults use Algoxib?

Algoxib is indicated for a range of uses in adults, which covers the young adult population. The established dosing regimens are intended for adult patients, generally starting at 18 years of age.

Q: How quickly does Algoxib start working?

Based on pharmacokinetic data, the concentration of the drug in the blood generally reaches its peak level approximately three hours after a dose, when taken on an empty stomach. This time is an indication of when the substance is most available in the body.

Q: How long does the effect of Algoxib last?

Pharmacokinetic data in the official label indicates that the effective half-life (the time it takes for half the drug to be eliminated from the body) is approximately 11 hours when taken on an empty stomach.

Q: Is it common to feel tired when taking Algoxib?

Feeling tired or fatigued is not listed as a common side effect in the primary regulatory safety profile. However, symptoms like asthenia (general weakness) have been noted in less frequent or post-marketing reports for this type of medication.

Q: What if I'm already taking medicine for depression? Does Algoxib interact?

Regulatory drug interaction information lists Selective Serotonin Reuptake Inhibitors ( SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors ( SNRIs) as interacting agents. These are common depression medicines and their co-administration with Algoxib may increase the risk of bleeding.

Q: Are there any long-term effects of taking Algoxib for a few years?

Official regulatory warnings state that the risk of serious cardiovascular thrombotic events, such as heart attack or stroke, may increase with the duration of use. Because of this, the medication is advised to be used for the shortest possible duration consistent with the patient's treatment goals.

Q: Why do official documents mention heart risk with this type of drug?

The mechanism of Algoxib involves inhibiting the COX-2 enzyme, which affects the balance of certain natural chemicals ( prostanoids) that help regulate blood vessels. Regulatory documents highlight this mechanism's influence on cardiovascular pathways, leading to the requirement for specific warnings regarding heart risk.

Q: Does Algoxib interact with herbal supplements?

Regulatory safety information generally advises that patients should inform their healthcare provider of all products they take, which includes prescription and over-the-counter medicines, vitamins, and herbal supplements. This practice is advised because certain supplements may increase the risk for serious side effects.

Q: Can I take Algoxib if I have asthma?

Regulatory documents caution about the risk of exacerbation of asthma related to aspirin sensitivity. Algoxib should not be used in people who have had asthma, hives ( urticaria), or other allergic-type reactions after taking aspirin or other non-steroidal anti-inflammatory drugs ( NSAIDs).

Q: Does Algoxib make me more sensitive to the sun?

Regulatory documentation lists photosensitivity (sensitivity of the skin to sunlight) as a less common or post-marketing adverse reaction. This means it is an effect that has been reported, but not one of the most frequently observed side effects.

Q: Can Algoxib be used for pain after dental work?

Algoxib is indicated for the management of acute pain. Official information also advises patients to inform their dentist that they are taking Algoxib if they are having any surgery, including dental procedures, so that care decisions can be appropriately made.

Q: Does Algoxib interact with alcohol?

Official warnings state that consuming alcohol while taking Algoxib can increase the risk of serious gastrointestinal side effects. This includes an increased risk for bleeding, ulceration, and perforation in the stomach or intestines.

Q: Are there any known issues with fertility while taking Algoxib?

Regulatory labeling includes a section on reproductive potential. Based on the mechanism of action, the use of NSAIDs like Algoxib may be associated with a reversible delay in ovulation.

Q: Can Algoxib affect vision?

Regulatory documents list blurred vision as a reported adverse reaction. This effect is categorized as less common or noted in post-marketing experience rather than being a frequent side effect observed in clinical trials.

Q: Does taking Algoxib require regular check-ups with a doctor?

For patients using the medication long-term, official regulatory guidance includes monitoring recommendations. These include regularly assessing blood pressure and watching for signs of gastrointestinal bleeding, which implies the need for regular communication and check-ups with a healthcare provider.

How should Algoxib be stored and disposed of?

How to Store and Dispose of Algoxib

The storage and disposal of Algoxib must strictly follow the official instructions provided on the regulatory label to maintain stability and ensure safety.

Requirement Official Regulatory Instruction
Storage Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Keep from freezing and do not store above 30 C.
Container & Protection Keep the medicine in its original, closed container, away from heat, moisture, and direct light. Must be stored out of the reach of children.
Stability After Mixing The capsule contents, when mixed with applesauce, rice gruel, or yogurt, are stable for up to 6 hours only if refrigerated (2 C to 8 C).
Disposal Method Dispose of unused or expired product according to local regulations. The official method is often a drug take-back program or by mixing with an undesirable substance in the household trash. Do not allow the product to enter drains or the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Algoxib found in:

A-Z Index: